Sleep, recovery & research
DSIP and the search for better sleep.
Find a clearer next step.
When sleep is not restoring you, another difficult night can make every new idea feel urgent. Understand DSIP research, then discuss the assessment and care options your sleep deserves.
Research discussion · Any access requires individual review and authorization.
Questions worth exploring
Personal care. Clear costs.
Understand your options.
Choose your next step.
Start with your goals and a clinician conversation. Review your eligible care options and exact costs before payment.
SEINE BIO selected catalog option*
DSIP · program discussion
From $80per 5 mg cartridge*
Current catalog price for a 5 mg cartridge. Access is considered case by case after clinical review and any required program authorization. A particular treatment or research placement is not guaranteed.
The displayed catalog price is for the named form and quantity; it is not a monthly treatment quote. Approved medications ship according to your approved care plan. Confirm the exact product or program, what is included, package length, total upfront payment, any labs, shipping or tax charges, and cancellation and refund terms before purchase.
Ask about my care optionsNo payment with your inquiry. Final availability and price are confirmed after review.
Optional product-savings membership
Personal guidance. Ongoing support.
$20SEINE Plus · Per month · Cancel anytime
- 2% off products; therapy services and membership dues excluded
- Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
- Paid membership is optional; a free account lets you request review and purchase
- Cancel anytime to stop future membership renewals
Optional memberships: SEINE Plus is $20/month and SEINE Premier is $80/month, billed monthly until you cancel. Compare plan benefits and exclusions. Existing members retain their current plan terms.
Create a free account ↗Membership and cancellation details →*Catalog prices are for the named form and quantity, separate from membership. Required supply and your total are confirmed before purchase. Investigational treatments require additional eligibility review and authorization.
Understand the topic
DSIP / Emideltide.
A clearer overview.
Start with the research. Keep your goals in view.
Research topic. DSIP is not an FDA-approved insomnia, narcolepsy or opioid-withdrawal medicine. This page offers research education and a discussion of appropriate care.
What makes it interesting.
Delta sleep-inducing peptide, also called DSIP or Emideltide, is a nine-amino-acid peptide. Its name comes from early experiments involving brain-wave activity. Its role in natural human sleep regulation and the mechanism of a therapeutic effect are not established by that name.
The story behind the interest.
Schoenenberger and Monnier described the peptide in a 1977 rabbit study. The original work involved direct brain administration in an experimental setting. Later human sleep studies explored different exposures, which is why the route, study design and actual sleep outcomes matter more than the label.
Evidence before expectations
Read beyond
the headline.
A useful research discussion includes the study design, the population and the outcome measured.
Read the original sourcesThe early rabbit experiment helped characterize DSIP and its effects on electrical brain activity. It did not establish a routine human treatment, and its experimental route is not a model for consumer use.
FDA’s 2026 briefing reviews older human insomnia studies, including a study reporting little therapeutic benefit and no significant difference in objective sleep measures or subjective sleep quality compared with placebo.
A sleep problem can involve insomnia, irregular schedules, breathing disturbances, medication effects or another condition. The most useful care conversation starts with what happens at night and how you function during the day rather than assuming that one research peptide fits every pattern.
| Research setting | What the record shows | What it does not establish |
|---|---|---|
| 1977 discovery study | DSIP was characterized through experiments in rabbits. | Does not establish human effectiveness or safety. |
| Human sleep studies | Older studies used limited samples and different routes. | Results do not provide a reliable routine treatment standard. |
| 2026 FDA review | Emideltide was reviewed for several proposed uses. | The review is separate from drug approval and access. |
Understand the evidence
Understanding doses
and cycles.
A clear reference for your conversation with a clinician.
Research doses describe a specific study, not a treatment plan. Online popularity does not establish safety.
| Preparation / context | Dose reference | Frequency | Duration / cycle | Evidence & source |
|---|---|---|---|---|
| DSIP / Emideltide | Not established for this proposed wellness use | Not established | No validated human on/off cycle | Evidence limitations A generic sleep cycle is not an established regimen. Read the source |
Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.
Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.
Discuss my optionsAn honest view of uncertainty
Ask better questions.
Understand the concerns.
Missing safety information cannot be treated as proof that a product is safe.
Risks & concerns
What deserves attention.
- Limited and route-specific evidence leaves long-term safety and interactions unresolved.
- FDA describes incomplete safety information for the proposed preparation and immune-response concerns.
- An experimental compound should not delay assessment of severe daytime sleepiness, breathing problems or medication-related sleep changes.
A compound’s name, a purity claim or research-use labeling does not establish patient-ready quality, sterility or a reliable clinical outcome.
Regulatory context
Review is not an approval.
Emideltide free base and acetate were on the July 2026 compounding agenda. The proposed uses included insomnia, narcolepsy and opioid withdrawal; evaluation does not mean those uses are approved.
Compounding review, permission to conduct research and approval of a finished drug are different decisions. This page is an invitation to learn and discuss appropriate care, not a statement that this compound can be supplied.
Check the official sourcesThe goal behind your search
Rest matters.
Give your sleep a real assessment.
Tell us whether the challenge is falling asleep, staying asleep, waking too early or feeling unrefreshed. A clinician can help determine the right evaluation and discuss established options. Research can be part of the conversation without becoming a substitute for care.
Share your goal.
Create a free account. Tell the team which care conversation interests you; keep sensitive health details for private clinical intake.
Understand your options.
The appropriate clinician can discuss the research, its limitations and established alternatives. Relevant research resources may be discussed when appropriate; eligibility and access are controlled by the study or sponsor.
Choose your next step.
Review suitability, available care and clear costs before deciding. A plan may involve established treatment, a referral or further assessment. No particular prescription or research access is guaranteed.
Good questions welcome
Make the next
step clearer.
You can be curious about research and still choose a practical care path available today.
Does the name mean DSIP reliably induces deep sleep?
No. The name reflects early experimental findings. It is not a guarantee of a clinical effect. Human evidence needs to show meaningful improvements in sleep and daytime function.
Is DSIP a replacement for sleep assessment?
No. Persistent insomnia and excessive sleepiness can have different causes and require different care. Discuss the pattern and severity with an appropriate clinician.
Can it be used to manage opioid withdrawal?
This page does not recommend that use. Opioid withdrawal and substance-use treatment should be managed with a qualified clinician using an appropriate care plan, rather than an experimental peptide.
What happens after I submit an inquiry?
The team explains the appropriate next step and costs. Any clinical care requires individual assessment. An inquiry does not promise DSIP treatment, a clinical-trial place or a prescription.
A simple place to start
Bring your questions.
Explore your next step.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
- A free account with basic contact details
- Screening and clear costs before payment
- Established alternatives discussed when appropriate
An inquiry is not an application for guaranteed access to this compound. Membership does not include or guarantee experimental treatment. Any clinical care and costs will be explained separately.
Start with a free account.
SEINE Plus: $20/month. SEINE Premier: $80/month.
Optional plans · Billed monthly · Cancel anytime. Medications, labs, products, additional therapy and separately priced treatments cost extra.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
Please keep medical history, medications and sensitive personal details for private clinical intake.
Learn more
Read the sources.
Bring your questions.
Original research and official regulatory materials help put claims into context. Study links are educational and do not establish a treatment offer.
Reviewed October 7, 2026. Regulatory status and research records may change.
Questions about DSIP / Emideltide?Start a care conversation
Start my inquiryClinical inquiries: age 18+. Research information does not imply treatment availability. Clinical decisions require an individual evaluation by an appropriate licensed clinician. An inquiry or membership does not guarantee a prescription, research enrollment or a specific outcome.
We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.